|
2023
|
Invention
|
Morphinan compounds. 1 receptor agonist that also has NMDA antagonist activity. |
|
2022
|
Invention
|
Combination of morphinan compounds and antidepressant for the treatment of pseudobulbar affect, n... |
|
|
Invention
|
Morphinan compounds.
This disclosure relates to novel morphinan compounds and their derivatives,... |
|
|
Invention
|
Treatment of jak-inhibition-responsive disorders with prodrugs of jak inhibitors. A method of tre... |
|
|
Invention
|
Treatment of hair loss disorders with deuterated jak inhibitors. A method of treating a JAK-inhib... |
|
2021
|
Invention
|
Process for preparing enantiomerically enriched jak inhibitors. Certain aspects of the present in... |
|
|
Invention
|
Methods and intermediates for preparing jak inhibitors. Improved processes and intermediates for ... |
|
2020
|
Invention
|
Deuterated derivatives of ruxolitinib.
The present invention in one embodiment provides a compou... |
|
|
Invention
|
Deuterated analogs of d-beta-hydroxybutyric acid and uses thereof.
This disclosure relates to de... |
|
|
Invention
|
Novel deuterated jak inhibitor and uses thereof. Disclosed is a JAK1 and/or JAK2 inhibitor of the... |
|
|
Invention
|
Methods of treatment with deuterated analogs of d-serine. This disclosure relates to deuterated D... |
|
|
Invention
|
Deuterated analogs of d-serine and uses thereof. This disclosure relates to deuterated D-serine, ... |
|
|
Invention
|
Processes for the preparation of deuterated d-serine. Disclosed are methods for preparing deutera... |
|
|
Invention
|
Process for preparing enantiomerically enriched jak inhibitors. Improved processes and intermedia... |
|
2019
|
Invention
|
Deuterated forms and derivatives of volinanserin. Deuterated forms of volinanserin according to s... |
|
|
Invention
|
Deuterated pitolisant. This invention also provides compound of Formula (I) including pharmaceuti... |
|
|
Invention
|
Deuterated morphinan compounds for treating agitation.
This invention relates to methods of trea... |
|
|
Invention
|
Deuterated analogs of d-β-hydroxybutyric acid and uses thereof. This disclosure relates to deuter... |
|
2018
|
Invention
|
Deuterated palbociclib.
This invention relates to novel pyrido[2,3-d]pyrimidinones of Formula I:... |
|
|
Invention
|
4-hydroxybutyric acid analogs.
This invention relates to novel derivatives of 4-hydroxybutyric a... |
|
2017
|
Invention
|
Deuterated quinoxaline compounds. This invention relates to novel 2,3,6b,7,8,9,10,10a-octahydro-1... |
|
|
Invention
|
Deuterated cenicriviroc. This invention relates to deuterated forms of cenicriviroc, racemic and ... |
|
|
Invention
|
Deuterated lurasidone. This invention relates to deuterated forms of hexahydro-4,7-methano-1H-iso... |
|
|
Invention
|
Deuterated idalopirdine. This invention relates to indol-3-yl)ethyl]-3-(tetrafluoropropoxy)benzyl... |
|
|
Invention
|
Deuterated miconazole. This invention relates to deuterated forms of miconazole and pharmaceutica... |
|
|
Invention
|
Deuterated venetoclax.
This invention relates to deuterated forms of venetoclax, and pharmaceuti... |
|
|
Invention
|
Deuterated venetoclax. This invention relates to deuterated forms of venetoclax, and pharmaceutic... |
|
|
Invention
|
Deuterated bictegravir. This invention relates to deuterated forms of bictegravir, and pharmaceut... |
|
|
Invention
|
Deuterated fevipiprant. This invention relates to novel pyrrolo[2,3-b]pyridine compounds, and pha... |
|
|
Invention
|
Substituted triazolobenzodiazepines. This invention relates to novel substituted triazolobenzodia... |
|
|
Invention
|
Combination therapy for treating cancer. The invention is directed to compositions and combinatio... |
|
|
Invention
|
Treatment of hair loss disorders with deuterated jak inhibitors. Disclosed is a method of treatin... |
|
|
Invention
|
Deuterated gft-505. This invention relates to novel deuterated forms of GFT-505, and pharmaceutic... |
|
|
Invention
|
Deuterated tozadenant. This invention relates to deuterated forms of morpholinobenzo[d]thiazol-2-... |
|
2016
|
Invention
|
Deuterated iti-007. This invention relates to novel 2,3,6b,7,8,9,10,10a-octahydro-1H-pyrido[3',4'... |
|
|
Invention
|
Deuterated epi-743. This invention relates to novel α-tocotrienol quinones of Formula I: (I), and... |
|
|
Invention
|
Deuterated morphinan compounds for use in treating agitation. This invention relates to methods o... |
|
|
Invention
|
Morphinan compounds for use in treating agitation. This invention relates to methods of treating ... |
|
|
Invention
|
Morphinan compounds for treating agitation. This invention relates to methods of treating agitati... |
|
2015
|
Invention
|
Methods of treating hyperglycemia.
The present invention relates to a novel method of treating h... |
|
2013
|
G/S
|
Pharmaceutical preparations for the treatment of diabetic nephropathy, multiple myeloma, and spas... |
|
|
G/S
|
Pharmaceutical preparations; biopharmaceutical preparations; pharmaceutical and biopharmaceutical... |
|
2007
|
G/S
|
Pharmaceutical and veterinary preparations; biopharmaceutical preparations; full line of pharmace... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of inflammatory diseases, namely, inflammatory bowe... |
